IV Iron in Acute Decompensated Heart Failure

Summary

The study aims Compare the effect of addition of IV FERRLECITR (ferric gluconate) to standard therapy to standard therapy alone (without any IV iron treatment) in patients admitted with acute decompensated heart failure.

Timeline

Start

2019-09-01

Primary completion

2021-12-31

Completion

2021-12-31

Publications

• Marcusohn E, Borreda I, Hellman Y, Habib M, Bahouth F, Epstein D, Zukermann R. IV Sodium Ferric Gluconate Complex in Patients With Iron Deficiency Hospitalized due to Acute Heart Failure-Investigator Initiated, Randomized Controlled Trial. J Cardiovasc Pharmacol. 2022 Aug 1;80(2):194-196. doi: 10.1097/FJC.0000000000001287.

Drugs

Indications